The objective of this study was to investigate the response of IgA and IgG antibodies to SARS-CoV-2 in serial blood samples collected from a population of Thai patients with confirmed COVID-19, and the association of these responses with the severity of the illness. The gene discussed is CD79A; the disease is COVID-19.